N. Scheiermann

606 total citations
47 papers, 404 citations indexed

About

N. Scheiermann is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, N. Scheiermann has authored 47 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 15 papers in Immunology and 14 papers in Hepatology. Recurrent topics in N. Scheiermann's work include Hepatitis B Virus Studies (25 papers), Hepatitis C virus research (9 papers) and Hepatitis Viruses Studies and Epidemiology (6 papers). N. Scheiermann is often cited by papers focused on Hepatitis B Virus Studies (25 papers), Hepatitis C virus research (9 papers) and Hepatitis Viruses Studies and Epidemiology (6 papers). N. Scheiermann collaborates with scholars based in Germany, Slovakia and United States. N. Scheiermann's co-authors include E. Kreuzfelder, R. Berger, M Just, E. Kuwert, O. Thraenhart, Ralf Clemens, R Baumgaŕten, Thomas Löscher, Hans L. Bock and Manfred Wiese and has published in prestigious journals such as The Lancet, Plastic & Reconstructive Surgery and Vaccine.

In The Last Decade

N. Scheiermann

44 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Scheiermann Germany 12 228 143 100 80 38 47 404
J Slusarczyk Poland 14 444 1.9× 285 2.0× 45 0.5× 90 1.1× 14 0.4× 71 622
Tijen Özacar Türkiye 13 380 1.7× 275 1.9× 33 0.3× 67 0.8× 17 0.4× 32 484
Iwao Ariyama Japan 11 278 1.2× 273 1.9× 69 0.7× 65 0.8× 21 0.6× 21 457
A. Kipps South Africa 12 238 1.0× 34 0.2× 63 0.6× 80 1.0× 13 0.3× 33 320
Alireza Janbakhsh Iran 12 175 0.8× 73 0.5× 39 0.4× 98 1.2× 25 0.7× 49 400
Alberto Spanò Italy 13 188 0.8× 92 0.6× 44 0.4× 110 1.4× 34 0.9× 18 373
Mary Rinki United States 10 654 2.9× 125 0.9× 292 2.9× 181 2.3× 62 1.6× 10 893
Alessandra Zappá Italy 15 400 1.8× 127 0.9× 31 0.3× 113 1.4× 15 0.4× 23 452
Sean Bennett United States 13 272 1.2× 116 0.8× 192 1.9× 170 2.1× 10 0.3× 39 640
G. Dal Molin Italy 13 319 1.4× 239 1.7× 24 0.2× 97 1.2× 23 0.6× 29 480

Countries citing papers authored by N. Scheiermann

Since Specialization
Citations

This map shows the geographic impact of N. Scheiermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Scheiermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Scheiermann more than expected).

Fields of papers citing papers by N. Scheiermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Scheiermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Scheiermann. The network helps show where N. Scheiermann may publish in the future.

Co-authorship network of co-authors of N. Scheiermann

This figure shows the co-authorship network connecting the top 25 collaborators of N. Scheiermann. A scholar is included among the top collaborators of N. Scheiermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Scheiermann. N. Scheiermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lemperle, Gottfried, Pierre Nicolau, & N. Scheiermann. (2011). Is There Any Evidence for Biofilms in Dermal Fillers?. Plastic & Reconstructive Surgery. 128(2). 84e–85e. 14 indexed citations
2.
Bock, Hans L., Thomas Löscher, N. Scheiermann, et al.. (1995). Accelerated Schedule for Hepatitis B Immunization. Journal of Travel Medicine. 2(4). 213–217. 47 indexed citations
3.
Scheiermann, N., et al.. (1994). Hepatitis B vaccination of blood donors--a cost-benefit analysis.. PubMed. 32. 110–2. 2 indexed citations
4.
Kallinowski, B., K. Gmelin, B Kommerell, et al.. (1992). Immunogenicity, reactogenicity and consistency of a new, inactivated hepatitis A vaccine — a randomized multicentre study with three consecutive vaccine lots. Vaccine. 10(8). 500–501. 6 indexed citations
5.
Scheiermann, N., et al.. (1992). Enumeration of T, B and Natural Killer Peripheral Blood Cells of Patients with Multiple Sclerosis and Controls. European Neurology. 32(4). 190–194. 26 indexed citations
6.
Theilmann, Lorenz, B. Kallinowski, K. Gmelin, et al.. (1992). Reactogenicity and immunogenicity of three different lots of a hepatitis A vaccine. Vaccine. 10. S132–S134. 11 indexed citations
7.
Kreuzfelder, E., U. Obertacke, J. Erhard, et al.. (1991). Alterations of the Immune System Following Splenectomy in Childhood. The Journal of Trauma: Injury, Infection, and Critical Care. 31(3). 358–364. 10 indexed citations
8.
9.
Kreuzfelder, E., Heinz-Otto Keinecke, U. Obertacke, et al.. (1988). Adult Respiratory Distress Syndrome as a Specific Manifestation of a General Permeability Defect in Trauma Patients. American Review of Respiratory Disease. 137(1). 95–99. 27 indexed citations
10.
Biniek, R., M. Schulz, H. Lehmann, et al.. (1988). Intrathecal production of HIV antibodies in suspected AIDS encephalopathy. Journal of Neurology. 235(3). 131–135. 13 indexed citations
11.
Just, M, R. Berger, & N. Scheiermann. (1988). Persistence of antibodies following vaccination with a yeast-derived recombinant hepatitis B vaccine. Vaccine. 6(5). 401–402. 15 indexed citations
12.
Trenn, Guido, et al.. (1988). Age-Associated T-Lymphocyte Activation through Mitogens in Patients with Multiple Sclerosis and Blood Donors. European Neurology. 28(1). 47–50. 6 indexed citations
13.
Brockmeyer, Norbert H., E. Kreuzfelder, Wilhelm Kirch, et al.. (1988). Immunomodulatory properties of cimetidine in ARC patients. Clinical Immunology and Immunopathology. 48(1). 50–60. 28 indexed citations
14.
Scheiermann, N., et al.. (1987). Reactogenicity and immunogenicity of the newly developed Purified Chick Embryo Cell (PCEC)-rabies vaccine in man. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A Medical Microbiology Infectious Diseases Virology Parasitology. 265(3-4). 439–450. 17 indexed citations
15.
Wiedermann, G, N. Scheiermann, Patrick Goubau, et al.. (1987). Multicentre dose range study of a yeast-derived hepatitis B vaccine. Vaccine. 5(3). 179–183. 24 indexed citations
16.
Scheiermann, N. & E. Kuwert. (1984). Active Hepatitis B Immunization with an Experimental German Vaccine I. Immunogenicity Studies in Healthy Adults II. The Primary 19 S and 7 S Responses to HBsAg in Healthy Adults III. Immunogenicity Studies in Hemodialysis Patients. Zentralblatt für Bakteriologie Mikrobiologie und Hygiene 1 Abt Originale A Medizinische Mikrobiologie Infektionskrankheiten und Parasitologie. 257(3). 439–455. 1 indexed citations
17.
Scheiermann, N., et al.. (1979). [Studies on human immunoglobulin preparations: I. Viral antibody profiles (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 74(21). 820–4. 3 indexed citations
18.
Thraenhart, O., et al.. (1978). Influence of different disinfection conditions on the structure of the hepatitis B virus (Dane particle) as evaluated in the morphological alteration and disintegration test (MADT).. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 242(3). 299–314. 4 indexed citations
19.
Kuwert, E., et al.. (1977). Neuraminidase antibodies in serum and nasal washings after immunization by means of live and killed whole virion, split virion and subunit (HA and N) influenza vaccines.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 39. 77–83. 4 indexed citations
20.
Thraenhart, O., et al.. (1977). [Morphological alteration and desintegration of dane particles after exposure with "Gigasept". A first methological attempt for the evaluation of the virucidal efficacy of a chemical disinfectant against hepatitisvirus B ( author's transl)].. PubMed. 164(1-2). 1–21. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Slusarczyk Breakdown of academic impact, for papers by Tijen Özacar Breakdown of academic impact, for papers by Iwao Ariyama Breakdown of academic impact, for papers by A. Kipps Breakdown of academic impact, for papers by Alireza Janbakhsh Breakdown of academic impact, for papers by Alberto Spanò Breakdown of academic impact, for papers by Mary Rinki Breakdown of academic impact, for papers by Alessandra Zappá Breakdown of academic impact, for papers by Sean Bennett Breakdown of academic impact, for papers by G. Dal Molin
Rankless by CCL
2026